SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-046881
Filing Date
2024-04-23
Accepted
2024-04-23 16:05:09
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A apvo-2024-def14a_-_proxy.htm DEF 14A 1357734
2 GRAPHIC img167027806_0.jpg GRAPHIC 45134
3 GRAPHIC img167027806_1.jpg GRAPHIC 45134
4 GRAPHIC img167027806_2.jpg GRAPHIC 45134
5 GRAPHIC img167027806_3.jpg GRAPHIC 45134
6 GRAPHIC img167027806_4.jpg GRAPHIC 45134
7 GRAPHIC img167027806_5.jpg GRAPHIC 47859
8 GRAPHIC img167027806_6.jpg GRAPHIC 45134
9 GRAPHIC img167027806_7.jpg GRAPHIC 45134
10 GRAPHIC img167027806_8.jpg GRAPHIC 45134
11 GRAPHIC img167027806_9.jpg GRAPHIC 6175
12 GRAPHIC img167027806_10.jpg GRAPHIC 42115
13 GRAPHIC img167027806_11.jpg GRAPHIC 159989
14 GRAPHIC img167027806_12.jpg GRAPHIC 463149
15 GRAPHIC img167027806_13.jpg GRAPHIC 403503
  Complete submission text file 0000950170-24-046881.txt   3398540
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37746 | Film No.: 24864815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)